A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
Miltenyi Biomedicine GmbH
Atara Biotherapeutics
Karyopharm Therapeutics Inc
Morphotek
INSYS Therapeutics Inc
Novartis